Article ; Online: Glycyl-l-histidyl-l-lysine-Cu
Journal of cachexia, sarcopenia and muscle
2023 Volume 14, Issue 3, Page(s) 1365–1380
Abstract: ... sectional area elevated (1055 ± 552.4 μm: Conclusions: Plasma glycyl-l-histidyl-l-lysine level ... associated with skeletal muscle mass. Exogenous administration of glycyl-l-histidyl-l-lysine-Cu ...
| Abstract | Background: Skeletal muscle dysfunction is an important co-morbidity in patients with chronic obstructive pulmonary disease (COPD) and is significantly associated with increased mortality. Oxidative stress has been demonstrated an important trigger for COPD-related skeletal muscle dysfunction. Glycine-histidine-lysine (GHK) is an active tripeptide, which is a normal component of human plasma, saliva, and urine; promotes tissue regeneration; and acts as an anti-inflammatory and antioxidant properties. The purpose of this study was to determine whether GHK is involved in COPD-related skeletal muscle dysfunction. Methods: The plasma GHK level in patients with COPD (n = 9) and age-paired healthy subjects (n = 11) were detected using reversed-phase high-performance liquid chromatography. The complex GHK with Cu (GHK-Cu) was used in in vitro (C2C12 myotubes) and in vivo experiments (cigarette smoking [CS]-exposure mouse model) to explore the involvement of GHK in CS-induced skeletal muscle dysfunction. Results: Compared with healthy control, plasma GHK levels were decreased in patients with COPD (70.27 ± 38.87 ng/mL vs. 133.0 ± 54.54 ng/mL, P = 0.009). And plasma GHK levels in patients with COPD were associated with pectoralis muscle area (R = 0.684, P = 0.042), inflammatory factor TNF-α (R = -0.696, P = 0.037), and antioxidative stress factor SOD2 (R = 0.721, P = 0.029). GHK-Cu was found to rescue CSE-induced skeletal muscle dysfunction in C2C12 myotubes, as evidenced by increased expression of myosin heavy chain, reduced expression of MuRF1 and atrogin-1, elevated mitochondrial content, and enhanced resistance to oxidative stress. In CS-induced muscle dysfunction C57BL/6 mice, GHK-Cu treatment (0.2 and 2 mg/kg) reduces CS-induced muscle mass loss (skeletal muscle weight (1.19 ± 0.09% vs. 1.29 ± 0.06%, 1.40 ± 0.05%; P < 0.05) and muscle cross-sectional area elevated (1055 ± 552.4 μm Conclusions: Plasma glycyl-l-histidyl-l-lysine level in patients with chronic obstructive pulmonary disease was significantly decreased and was significantly associated with skeletal muscle mass. Exogenous administration of glycyl-l-histidyl-l-lysine-Cu |
|---|---|
| MeSH term(s) | Humans ; Mice ; Animals ; Lysine/metabolism ; Sirtuin 1/metabolism ; Cigarette Smoking ; Mice, Inbred C57BL ; Muscle, Skeletal/metabolism ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Antioxidants/metabolism ; Pulmonary Disease, Chronic Obstructive/metabolism |
| Chemical Substances | Lysine (K3Z4F929H6) ; Sirtuin 1 (EC 3.5.1.-) ; Antioxidants |
| Language | English |
| Publishing date | 2023-03-10 |
| Publishing country | Germany |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 2586864-0 |
| ISSN | 2190-6009 ; 2190-5991 |
| ISSN (online) | 2190-6009 |
| ISSN | 2190-5991 |
| DOI | 10.1002/jcsm.13213 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.